Browse articles on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
The EVO Visian ICL (STAAR Surgical) was recently approved for the treatment of myopia and astigmatism, with updates to the previous ICL technology. Several physicians discussed the technology with EyeWorld: what’s new, how they’re using the product, and results they’ve seen so far.
When treating endothelial dysfunction, surgeons have several options. The current standard of care is endothelial keratoplasty, DSAEK and DMEK. One new therapy that has been getting a lot of attention is corneal endothelial cell therapy, and there has been significant progress in the last 18 months.
Two physicians shared their reasons for and experiences with combining MIGS procedures.
January is an important month for businesses, and arguably the most important month for achieving new year resolutions. Utilize time off during the holidays to analyze branding, employees, and operations. Executing the first month will set the stage for the rest of 2023, according to this article.
This has been a year of growth and appreciation for the ASCRS Foundation. This article recaps the successes of the Foundation over the past year and offers thanks to its supporters.
ASCRS Executive Director Steve Speares shared his thoughts on the year and why he is looking forward to 2023.
Four surgeons discussed the importance of ergonomics in ophthalmology, including their personal experiences and how they arrange their clinics and ORs for better ergonomics.
Two surgeons shared how they have incorporated small incision lenticule extraction (SMILE) into practice, what they’ve learned, and issues that may occur. They also addressed advancements and future innovation in the space.
The push for widespread COVID-19 vaccination has renewed the focus on the side effects that vaccines may have. It’s an especially unique situation due to the distinct timeframe for this mass vaccination campaign. Two experts spoke about potential ocular impacts of the vaccine and what physicians should look for.
When the term MIGS was first coined more than a decade ago, there were only a few options in the space. Since then, the MIGS space has grown significantly with many options addressing the same outflow pathway. As such, it might be time to start talking about MIGS in terms of procedural categories.